blog

National Glaucoma Classification Tool Urged for Widespread Adoption Glaucoma, often referred to as the “silent thief of sight,” is a leading cause of irreversible blindness worldwide. Early detection and accurate classification are critical to preventing vision loss, yet inconsistencies in diagnosis and staging persist across healthcare systems. To address this challenge, experts are now advocating […]

Are You Ignoring This Silent Cause of Vision Loss? Vision loss is often associated with aging, genetics, or obvious eye conditions like cataracts and glaucoma. But what if there’s a silent, overlooked culprit stealing your sight without warning? Many people dismiss early symptoms, assuming they’re temporary or harmless—until it’s too late. In this article, we’ll

Emerging Therapies Revolutionize Primary Open Angle Glaucoma Treatment Primary Open Angle Glaucoma (POAG) is the most common form of glaucoma, affecting millions worldwide. Characterized by progressive optic nerve damage and vision loss, POAG has long been managed with traditional treatments like eye drops, laser therapy, and surgery. However, recent advancements in medical science are revolutionizing

  Revolutionizing Glaucoma Treatment with Adaptive Trials and Patient Focus Introduction: The Urgent Need for Innovation in Glaucoma Care Glaucoma, a leading cause of irreversible blindness worldwide, affects over 80 million people. Traditional treatment methods, while effective to some extent, often lag behind the evolving needs of patients. The rise of adaptive clinical trials and

How DSLT Technology Improves Glaucoma Treatment Outcomes Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. Early detection and precise treatment are crucial to preventing vision loss. Traditional methods of managing glaucoma have relied on intraocular pressure (IOP) monitoring and surgical interventions. However, advancements in medical technology, such as Digital Scanning

Open Angle Glaucoma Market Growth Drives New Business Opportunities The global open-angle glaucoma market is experiencing significant growth, driven by increasing prevalence, technological advancements, and rising awareness about early diagnosis and treatment. As the most common form of glaucoma, open-angle glaucoma (OAG) affects millions worldwide, creating a substantial demand for innovative therapies and diagnostic tools.

Best Strategies for Glaucoma and Cataract Patient Outcomes Glaucoma and cataracts are two of the most common eye conditions affecting millions of people worldwide. While they differ in their causes and progression, both can lead to significant vision impairment if not managed properly. Early detection, personalized treatment plans, and patient education are key to improving

The Critical Link Between Blood Pressure and Glaucoma Management Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. While elevated intraocular pressure (IOP) is a well-known risk factor, emerging research highlights another critical player in glaucoma progression: blood pressure (BP). Understanding the relationship between blood pressure and glaucoma can help in

Perfuse Therapeutics Reports Positive Phase 1/2a Results for PER-001 Glaucoma Implant In a significant milestone for glaucoma treatment, Perfuse Therapeutics has announced encouraging results from its Phase 1/2a clinical trial for the PER-001 glaucoma implant. The novel device, designed to provide sustained intraocular pressure (IOP) reduction, demonstrated both safety and efficacy in early-stage testing, offering